Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model
Small interfering RNA (siRNA) therapy in acute myeloid leukemia (AML) is a promising strategy as the siRNA molecule can specifically target proteins involved in abnormal cell proliferation. The development of a clinically applicable method for delivering siRNA molecules is imperative due to the chal...
Saved in:
| Main Authors: | Panadda Yotsomnuk, Amarnath Praphakar Rajendran, Daniel Nisakar Meenakshi Sundaram, Luis Carlos Morales, Cezary Kucharski, Mohammad Nasrullah, Wanwisa Skolpap, Xiaoyan Jiang, Spencer B. Gibson, Joseph Brandwein, Hasan Uludağ |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/1/115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Facile and Promising Delivery Platform for siRNA to Solid Tumors
by: Qixin Leng, et al.
Published: (2024-11-01) -
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeutic
by: Katelyn Daman, et al.
Published: (2025-09-01) -
The biogenesis, regulation and functions of transitive siRNA in plants
by: Tan Huijun, et al.
Published: (2024-09-01) -
Small interfering RNA: From designing to therapeutic in cancer
by: Jyoti Singh, et al.
Published: (2025-06-01) -
Target mRNA abundance dilutes microRNA and siRNA activity
by: Aaron Arvey, et al.
Published: (2010-04-01)